M Uplekar

2.3k total citations
26 papers, 1.7k citations indexed

About

M Uplekar is a scholar working on Infectious Diseases, Epidemiology and Finance. According to data from OpenAlex, M Uplekar has authored 26 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 10 papers in Epidemiology and 7 papers in Finance. Recurrent topics in M Uplekar's work include Tuberculosis Research and Epidemiology (18 papers), Pneumonia and Respiratory Infections (8 papers) and Healthcare Systems and Reforms (7 papers). M Uplekar is often cited by papers focused on Tuberculosis Research and Epidemiology (18 papers), Pneumonia and Respiratory Infections (8 papers) and Healthcare Systems and Reforms (7 papers). M Uplekar collaborates with scholars based in Switzerland, United Kingdom and United States. M Uplekar's co-authors include Katherine Floyd, Christopher Dye, Sheela Rangan, Knut Lönnroth, Donald S. Shepard, Sudhakar Morankar, P Nunn, Sanjay Juvekar, Mario Raviǵlione and Salah-Eddine Ottmani and has published in prestigious journals such as European Respiratory Journal, Health Policy and Planning and The International Journal of Tuberculosis and Lung Disease.

In The Last Decade

M Uplekar

25 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
M Uplekar 1.3k 823 332 254 240 26 1.7k
Diana Weil 1.1k 0.8× 651 0.8× 241 0.7× 360 1.4× 321 1.3× 25 1.7k
Mukund Uplekar 1.3k 1.1× 865 1.1× 265 0.8× 283 1.1× 344 1.4× 25 1.7k
Fraser Wares 1.5k 1.2× 1.1k 1.3× 385 1.2× 142 0.6× 199 0.8× 52 1.7k
Daniel G. Datiko 944 0.7× 702 0.9× 251 0.8× 468 1.8× 203 0.8× 58 1.5k
Mohammed A. Yassin 1.3k 1.0× 1.1k 1.3× 535 1.6× 247 1.0× 96 0.4× 69 1.7k
A. M. V. Kumar 1.1k 0.8× 864 1.0× 345 1.0× 190 0.7× 131 0.5× 110 1.6k
Edina Sinanovic 908 0.7× 720 0.9× 201 0.6× 389 1.5× 191 0.8× 65 1.7k
Olivia Oxlade 2.0k 1.5× 1.4k 1.7× 799 2.4× 180 0.7× 163 0.7× 63 2.4k
Antônio Ruffino-Netto 1.3k 1.0× 649 0.8× 236 0.7× 156 0.6× 194 0.8× 176 2.1k
Hemant Deepak Shewade 811 0.6× 563 0.7× 158 0.5× 191 0.8× 117 0.5× 137 1.4k

Countries citing papers authored by M Uplekar

Since Specialization
Citations

This map shows the geographic impact of M Uplekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Uplekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Uplekar more than expected).

Fields of papers citing papers by M Uplekar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Uplekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Uplekar. The network helps show where M Uplekar may publish in the future.

Co-authorship network of co-authors of M Uplekar

This figure shows the co-authorship network connecting the top 25 collaborators of M Uplekar. A scholar is included among the top collaborators of M Uplekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Uplekar. M Uplekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyen, Linh, et al.. (2020). No universal access to drug-resistant tuberculosis care without engaging all health care providers. The International Journal of Tuberculosis and Lung Disease. 24(1). 118–123.
2.
Uplekar, M. (2016). Public-private mix for tuberculosis care and prevention. What progress? What prospects?. The International Journal of Tuberculosis and Lung Disease. 20(11). 1424–1429. 24 indexed citations
3.
Uplekar, M, et al.. (2013). Programmatic approaches to screening for active tuberculosis [State of the art series. Active case finding/screening. Number 6 in the series]. The International Journal of Tuberculosis and Lung Disease. 17(10). 1248–1256. 37 indexed citations
4.
Lönnroth, Knut, Elizabeth L. Corbett, Jonathan E. Golub, et al.. (2013). Systematic screening for active tuberculosis: rationale, definitions and key considerations [State of the art series. Active case finding/screening. Number 1 in the series]. The International Journal of Tuberculosis and Lung Disease. 17(3). 289–298. 119 indexed citations
5.
Boccia, Delia, James Hargreaves, Knut Lönnroth, et al.. (2011). Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications. The International Journal of Tuberculosis and Lung Disease. 15(6). 37–49. 95 indexed citations
6.
Creswell, Jacob, Mario Raviǵlione, Salah-Eddine Ottmani, et al.. (2010). Tuberculosis and noncommunicable diseases: neglected links and missed opportunities. European Respiratory Journal. 37(5). 1269–1282. 88 indexed citations
7.
Dye, Christopher, Katherine Floyd, & M Uplekar. (2008). Global tuberculosis control: surveillance planning financing. WHO report 2008.. 411 indexed citations
8.
Costa, Ayesha De, Tahseen Kazmi, Knut Lönnroth, M Uplekar, & Vinod Diwan. (2008). PPM: 'public-private' or 'private-public' mix? The case of Ujjain District, India.. PubMed. 12(11). 1333–5. 7 indexed citations
9.
Lönnroth, Knut, et al.. (2007). Social franchising of TB care through private GPs in Myanmar: an assessment of treatment results, access, equity and financial protection. Health Policy and Planning. 22(3). 156–166. 75 indexed citations
10.
Kluge, Hans, et al.. (2006). Private GPs contribute to TB control in Myanmar: evaluation of a PPM initiative in Mandalay Division.. PubMed. 10(9). 982–7. 36 indexed citations
11.
Lönnroth, Knut, et al.. (2005). Every provider counts: effect of a comprehensive public-private mix approach for TB control in a large metropolitan area in India.. PubMed. 9(5). 562–8. 38 indexed citations
12.
Uplekar, M, Sheela Rangan, Mitchell G. Weiss, et al.. (2001). Attention to gender issues in tuberculosis control.. PubMed. 5(3). 220–4. 86 indexed citations
13.
Ogden, Jane, Sheela Rangan, M Uplekar, et al.. (1999). Shifting the paradigm in tuberculosis control: illustrations from India.. PubMed. 3(10). 855–61. 38 indexed citations
14.
Harries, A D, Dermot Maher, M Uplekar, Mario Raviǵlione, & P Chaulet. (1997). TB: a clinical manual for South East Asia.. Medical Entomology and Zoology. 22 indexed citations
15.
Chakraborty, Amit K., Sheela Rangan, & M Uplekar. (1995). Urban tuberculosis control : problems and prospects. Medical Entomology and Zoology. 4 indexed citations
16.
Uplekar, M & Sheela Rangan. (1993). Private doctors and tuberculosis control in India. Tubercle and Lung Disease. 74(5). 332–337. 70 indexed citations
17.
Rangan, Sheela & M Uplekar. (1993). Community health awareness among recent medical graduates of Bombay.. PubMed. 6(2). 60–4. 7 indexed citations
18.
Uplekar, M & Richard A. Cash. (1991). The private GP and leprosy: a study. Leprosy Review. 62(4). 410–9. 8 indexed citations
19.
Uplekar, M & Donald S. Shepard. (1991). Treatment of tuberculosis by private general practitioners in India. Tubercle. 72(4). 284–290. 114 indexed citations
20.
Uplekar, M, et al.. (1988). Sympmed I: computer program for primary health care.. BMJ. 297(6652). 841–843. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026